Global Glabridin Market Growth 2025-2031
Description
The global Glabridin market size is predicted to grow from US$ 39.1 million in 2025 to US$ 59 million in 2031; it is expected to grow at a CAGR of 7.1% from 2025 to 2031.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
Glabridin is a naturally occurring flavonoid primarily extracted from the roots of Glycyrrhiza glabra (licorice). Renowned for its potent antioxidant and anti-inflammatory properties, glabridin is often incorporated into cosmetic formulations and skincare products to help brighten skin tone, reduce hyperpigmentation, and protect against oxidative stress. Beyond its dermatological benefits, ongoing research also investigates glabridin’s potential roles in metabolic health and inflammation management. Its efficacy and versatility, coupled with a relatively limited global supply, make glabridin a high-value active ingredient in both the personal care and nutraceutical industries.
The global Glabridin market shows a strong presence in Asia-Pacific, particularly driven by the high demand for skin-whitening products in countries such as China, South Korea, and Japan. In these markets, consumers prioritize natural and plant-derived actives, making Glabridin an attractive ingredient. Europe and North America also demonstrate steady growth, supported by a rising trend toward clean-label cosmetics and heightened awareness of the potential benefits of licorice root extracts. Meanwhile, emerging markets in Latin America and the Middle East are gradually embracing Glabridin-based formulations as consumer preferences shift toward safe and effective natural solutions.
Leading companies in the Glabridin sector include specialized botanical extract manufacturers and major cosmetic ingredient suppliers. These enterprises often invest heavily in research and development to refine extraction technologies—such as supercritical CO₂—and ensure high purity and consistent active content. Smaller, niche players also operate in the market, focusing on cost-effective or custom-formulated Glabridin extracts for targeted applications. Overall competition is shaped by product quality, supply-chain reliability, and brand recognition, with top manufacturers securing partnerships with global cosmetic brands seeking proven whitening and antioxidant solutions. The major global manufacturers of Glabridin include Sabinsa, Mafco, Maruzen Pharmaceuticals, Hyundai Bioland, Shanghai OLI, Lepro Herbals, Gansu Fanzhi Pharmaceutical, Qinghai Lake Pharmaceutical, and Hangzhou Lingeba Technology, etc. In 2024, the world's top three vendors accounted for approximately 32.88% of the revenue.
LP Information, Inc. (LPI) ' newest research report, the “Glabridin Industry Forecast” looks at past sales and reviews total world Glabridin sales in 2024, providing a comprehensive analysis by region and market sector of projected Glabridin sales for 2025 through 2031. With Glabridin sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Glabridin industry.
This Insight Report provides a comprehensive analysis of the global Glabridin landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Glabridin portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Glabridin market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Glabridin and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Glabridin.
This report presents a comprehensive overview, market shares, and growth opportunities of Glabridin market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Up to 20% (HPLC)
40% (HPLC)
60% (HPLC)
90% (HPLC)
98% (HPLC)
Segmentation by Application:
Creams and Lotions
Masks
Sunscreen Products
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Sabinsa
Mafco
Maruzen Pharmaceuticals
Hyundai Bioland
Shanghai OLI
Lepro Herbals
Gansu Fanzhi Pharmaceutical
Qinghai Lake Pharmaceutical
Hangzhou Lingeba Technology
Shaanxi Huatai Bio
Huzhou Ouli Biological Technology
Plamed Green Science Group
Xi'an Zhongying
Huaian Brothers Biotechnology
Alchem International
Ambe Phytoextracts
Sunpure Extracts
Novel Nutrientss
Key Questions Addressed in this Report
What is the 10-year outlook for the global Glabridin market?
What factors are driving Glabridin market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Glabridin market opportunities vary by end market size?
How does Glabridin break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
Glabridin is a naturally occurring flavonoid primarily extracted from the roots of Glycyrrhiza glabra (licorice). Renowned for its potent antioxidant and anti-inflammatory properties, glabridin is often incorporated into cosmetic formulations and skincare products to help brighten skin tone, reduce hyperpigmentation, and protect against oxidative stress. Beyond its dermatological benefits, ongoing research also investigates glabridin’s potential roles in metabolic health and inflammation management. Its efficacy and versatility, coupled with a relatively limited global supply, make glabridin a high-value active ingredient in both the personal care and nutraceutical industries.
The global Glabridin market shows a strong presence in Asia-Pacific, particularly driven by the high demand for skin-whitening products in countries such as China, South Korea, and Japan. In these markets, consumers prioritize natural and plant-derived actives, making Glabridin an attractive ingredient. Europe and North America also demonstrate steady growth, supported by a rising trend toward clean-label cosmetics and heightened awareness of the potential benefits of licorice root extracts. Meanwhile, emerging markets in Latin America and the Middle East are gradually embracing Glabridin-based formulations as consumer preferences shift toward safe and effective natural solutions.
Leading companies in the Glabridin sector include specialized botanical extract manufacturers and major cosmetic ingredient suppliers. These enterprises often invest heavily in research and development to refine extraction technologies—such as supercritical CO₂—and ensure high purity and consistent active content. Smaller, niche players also operate in the market, focusing on cost-effective or custom-formulated Glabridin extracts for targeted applications. Overall competition is shaped by product quality, supply-chain reliability, and brand recognition, with top manufacturers securing partnerships with global cosmetic brands seeking proven whitening and antioxidant solutions. The major global manufacturers of Glabridin include Sabinsa, Mafco, Maruzen Pharmaceuticals, Hyundai Bioland, Shanghai OLI, Lepro Herbals, Gansu Fanzhi Pharmaceutical, Qinghai Lake Pharmaceutical, and Hangzhou Lingeba Technology, etc. In 2024, the world's top three vendors accounted for approximately 32.88% of the revenue.
LP Information, Inc. (LPI) ' newest research report, the “Glabridin Industry Forecast” looks at past sales and reviews total world Glabridin sales in 2024, providing a comprehensive analysis by region and market sector of projected Glabridin sales for 2025 through 2031. With Glabridin sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Glabridin industry.
This Insight Report provides a comprehensive analysis of the global Glabridin landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Glabridin portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Glabridin market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Glabridin and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Glabridin.
This report presents a comprehensive overview, market shares, and growth opportunities of Glabridin market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Up to 20% (HPLC)
40% (HPLC)
60% (HPLC)
90% (HPLC)
98% (HPLC)
Segmentation by Application:
Creams and Lotions
Masks
Sunscreen Products
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Sabinsa
Mafco
Maruzen Pharmaceuticals
Hyundai Bioland
Shanghai OLI
Lepro Herbals
Gansu Fanzhi Pharmaceutical
Qinghai Lake Pharmaceutical
Hangzhou Lingeba Technology
Shaanxi Huatai Bio
Huzhou Ouli Biological Technology
Plamed Green Science Group
Xi'an Zhongying
Huaian Brothers Biotechnology
Alchem International
Ambe Phytoextracts
Sunpure Extracts
Novel Nutrientss
Key Questions Addressed in this Report
What is the 10-year outlook for the global Glabridin market?
What factors are driving Glabridin market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Glabridin market opportunities vary by end market size?
How does Glabridin break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
Table of Contents
142 Pages
- *This is a tentative TOC and the final deliverable is subject to change.*
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
